Biomatrix recently reported great earnings of $.50/share
last quarter as opposed to a loss in previous quarters. I heard
great things about this company from a friend. Biomatrix makes
many drugs including their biggest prospect called Synvisc. Synvisc
is a drug that is used to treat arthritis. FDA approval is supposed
to be coming real, real soon. The product I guess has done extremely
well in Europe and Canada causing the great increase in income last
quarter. I really feel the company has great potential. I have also
heard from my friend that insiders own a great portion of the stock.
Looking at the chart it looks like the time to get in is now.
If anyone has been following this stock I would greatly
appreciate your comments and feedback about the company. I would also
appreciate it if anyone could confirm, or at least tell me how to find
out about the insider holdings.
Thanks in advance, Andy |
